{
    "clinical_study": {
        "@rank": "109112", 
        "arm_group": [
            {
                "arm_group_label": "WATCHMAN", 
                "description": "Patients that had the WATCHMAN device implanted"
            }, 
            {
                "arm_group_label": "LARIAT LAA Device", 
                "description": "patients that had LARIAT LAA device implanted"
            }
        ], 
        "brief_summary": {
            "textblock": "Atrial fibrillation (AF) is the most common cardiac rhythm disorder in clinical practice. In\n      the last two decades the number of hospitalizations for AF has increased two- to three-fold.\n      More than 6 million people worldwide suffer from atrial fibrillation (AF), a cardiac\n      disorder that results in systemic emboli. Patients with AF are 5 times more likely to have a\n      stroke compared with those without AF.\n\n      This registry will collection information on two devices that are used to treat AF.  The\n      WATCHMAN and LARIAT.  The differences in techniques and subsequent effects of the two\n      devices on outcomes related to AF has not been studied. This study will look to compare the\n      two devices to see how the outcomes may vary."
        }, 
        "brief_title": "Safety and Efficacy of Left Atrial Appendage Occlusion Devices", 
        "completion_date": {
            "#text": "May 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Atrial Fibrillation", 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who have had a LARIAT LAA device occlusion\n\n        Exclusion Criteria:\n\n          -  Patients who have PFO/ASD/critical carotid artery (>70% blockage) disease and\n             hemorrhagic strokes"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients who have had a LARIAT LAA device occlusion."
            }
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01695564", 
            "org_study_id": "13240"
        }, 
        "intervention": [
            {
                "arm_group_label": "LARIAT LAA Device", 
                "description": "The LARIAT snare device is an over-the-wire device guided over the LAA to enable ligation of the LAA. The LARIAT can be opened and closed as desired for ideal positioning without risk of suture deployment.", 
                "intervention_name": "LARIAT LAA", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "WATCHMAN", 
                "description": "The WATCHMAN is an expandable device deployed in the LAA via a trans-septal catheter. The implanted device has a self-expanding nitinol frame to secure it in the LAA. The fabric of the WATCHMAN device is permeable to blood.", 
                "intervention_name": "WATCHMAN", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "atrial enlargement", 
            "left atrial appendage"
        ], 
        "lastchanged_date": "August 13, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Kansas City", 
                    "country": "United States", 
                    "state": "Kansas", 
                    "zip": "66160"
                }, 
                "name": "University of Kansas Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Comparison of Safety and Efficacy of Left Atrial Appendage Occlusion Devices", 
        "overall_official": {
            "affiliation": "University of Kansas", 
            "last_name": "Dhanunjaya Lakkireddy, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "This registry will provide data on patient outcomes at different times during follow up. This includes: changes in the appendage size, shape and patients medical history.", 
                "measure": "Effect of LAA occlusion by LARIAT device", 
                "safety_issue": "No", 
                "time_frame": "Change from Day 0 to Day 90"
            }, 
            {
                "description": "This registry will provide data on patient outcomes at different times during follow up.This includes: changes in the appendage size, shape and patients medical history.", 
                "measure": "Effect of LAA occlusion by LARIAT device", 
                "safety_issue": "No", 
                "time_frame": "Change from Day 0 to 356 post-procedure"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01695564"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Kansas Medical Center Research Institute", 
            "investigator_full_name": "Dhanunjaya Lakkireddy, MD, FACC", 
            "investigator_title": "Professor of Medicine", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Compare effectiveness of LAA occlusion procedure by evaluating LAA jet velocities", 
            "safety_issue": "No", 
            "time_frame": "Days 0, 90, 180, 365 post-procedure and annually thereafter"
        }, 
        "source": "University of Kansas", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dhanunjaya Lakkireddy, MD, FACC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}